Per the patient's mother (the patient is an unreliable historian), the patient never had a history of lithium or drug intoxication, has been noncompliant with medications in the past but not recently, and per mother the patient usually takes fewer pills of lithium but never overdoses.
On arrival to the Medical Intensive Care Unit, the patient was hydrated with intravenous fluids.
The patient has not required repeat dialysis after the initial first hemodialysis treatment.
She was also treated with Levaquin and Flagyl, and on transfer to the Medicine Service was day number three for aspiration pneumonia coverage.
The patient just began therapy with her psychiatrist two weeks ago (telephone number [**Telephone/Fax (1) 50093**]19).
Lithium 600 mg by mouth twice per day and 900 mg by mouth at hour of sleep.
Thiothixene 10 mg by mouth in the morning and 15 mg by mouth at hour of sleep.
MEDICATIONS PRIOR TO TRANSFER TO THE MEDICINE FLOOR: 1.
Levaquin 250 mg intravenously q.48h.
Heparin subcutaneously.
Insulin sliding-scale.
Thiothixene 15 mg by mouth in the evening and 10 mg by mouth in the morning.
Flagyl 250 mg intravenously q.6h.
Tylenol by mouth as needed.
Albuterol nebulizers q.4h.
PHYSICAL EXAMINATION ON PRESENTATION:  Physical examination revealed the patient's temperature was 98.9 degrees Fahrenheit, her blood pressure was 109/40, her heart rate was 84, her respiratory rate was 23, and her oxygen saturation was 95% on 5 liters via nasal cannula.
Gait testing was not assessed secondary to the patient's Quinton catheter in place.
Hemoglobin A1c was drawn but was pending.
The patient was status post hemodialysis times one and did not require any further hemodialysis treatment.
The Psychiatry attending continued to see the patient throughout her hospitalization, and lithium was not restarted until [**11-3**] in the evening at a reduced dose of 300 mg by mouth twice per day to adjust for her renal failure.
